Daniel M. Bendheim
Net Worth
Last updated:
What is Daniel M. Bendheim net worth?
The estimated net worth of Mr. Daniel M. Bendheim is at least $5,903,832 as of 30 Jan 2019. He owns shares worth $18,792 as insider and has received compensation worth at least $5,885,040 in Phibro Animal Health Corporation.
What is the salary of Daniel M. Bendheim?
Mr. Daniel M. Bendheim salary is $735,630 per year as Executive Vice President of Corporation Strategy & Director in Phibro Animal Health Corporation.
How old is Daniel M. Bendheim?
Mr. Daniel M. Bendheim is 53 years old, born in 1972.
What stocks does Daniel M. Bendheim currently own?
As insider, Mr. Daniel M. Bendheim owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Phibro Animal Health Corporation (PAHC) | Executive Vice President of Corporation Strategy & Director | 590 | $31.85 | $18,792 |
What does Phibro Animal Health Corporation do?
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Daniel M. Bendheim insider trading
Phibro Animal Health Corporation
Mr. Daniel M. Bendheim has made 25 insider trades between 2017-2019, according to the Form 4 filled with the SEC. Most recently he sold 2,390 units of PAHC stock on 30 Jan 2019.
The largest trade he's ever made was exercising 13,162 units of PAHC stock on 12 Mar 2018. As of 30 Jan 2019 he still owns at least 590 units of PAHC stock.
Phibro Animal Health key executives
Phibro Animal Health Corporation executives and other stock owners filed with the SEC:
- Mr. Damian Finio (55) Chief Financial Officer
- Mr. Daniel M. Bendheim (53) Executive Vice President of Corporation Strategy & Director
- Mr. Jack Clifford Bendheim (78) Chairman, Pres & Chief Executive Officer
- Mr. Larry L. Miller (61) Chief Operating Officer
- Mr. Thomas G. Dagger (67) Senior Vice President, Gen. Counsel & Corporation Sec.